Erlotinib vs Metronidazole
Erlotinib vs Metronidazole: Overview
This comparison examines the pharmacological differences between Erlotinib and Metronidazole.
Mechanism of Action
Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.
Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.
Pharmacokinetics
Half-life: Erlotinib β 36 hours; Metronidazole β 8 hours.
Chemical Properties
Molecular Formula: Erlotinib β C22H23N3O4; Metronidazole β C6H9N3O3.
Molecular Weight: Erlotinib β 393.4380 g/mol; Metronidazole β 171.1540 g/mol.
Type: Erlotinib β Small molecule; Metronidazole β Small molecule.